Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma

被引:30
作者
Nyenhuis, Sharmilee M. [1 ]
Alumkal, Preeth [2 ]
Du, Jian [2 ]
Maybruck, Brian T. [2 ]
Vinicky, Mark [1 ]
Ackerman, Steven J. [1 ,2 ]
机构
[1] Univ Illinois, Dept Med, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA
关键词
asthma; biomarker; eosinophil; sputum; MAJOR BASIC-PROTEIN; INDUCED SPUTUM; CATIONIC PROTEIN; PHENOTYPES; GALECTIN-10; PEROXIDASE; GRANULE; LYSOPHOSPHOLIPASE; EXACERBATIONS; DEGRANULATION;
D O I
10.2217/bmm-2018-0280
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Eosinophilic asthma is associated with more exacerbations and differential responses to treatment. The aim of this study was to assess if CLC/Gal-10 and MBP-1 are surrogate biomarkers of eosinophilic inflammation in asthma. Methods & results: Sputum induction was performed in patients with asthma and in healthy controls. Sputum analysis revealed higher (p < 0.001) levels of CLC/Gal-10 and MBP-1 in asthmatics versus healthy controls. CLC/Gal-10 levels were highly correlated (r(s) = 0.74; p < 0.001) with sputum eosinophils; MBP-1 approached significance (r = 0.44; p = 0.07). Conclusion: Increased CLC/Gal-10 andMBP-1 levels in the sputum were strongly correlated with sputum eosinophils in patients with asthma. CLC/Gal-10 and MBP-1 may be useful biomarkers for differentiation of eosinophilic airway inflammation in asthma.
引用
收藏
页码:715 / 724
页数:10
相关论文
共 37 条
[1]   Eosinophil Granule Proteins: Form and Function [J].
Acharya, K. Ravi ;
Ackerman, Steven J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (25) :17406-17415
[2]  
ACKERMAN SJ, 1993, J IMMUNOL, V150, P456
[3]  
ACKERMAN SJ, 1983, J IMMUNOL, V131, P2977
[4]   FORMATION OF CHARCOT-LEYDEN CRYSTALS BY HUMAN BASOPHILS [J].
ACKERMAN, SJ ;
WEIL, GJ ;
GLEICH, GJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1597-1609
[5]   Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion [J].
Ackerman, SJ ;
Liu, L ;
Kwatia, MA ;
Savage, MP ;
Leonidas, DD ;
Swaminathan, GJ ;
Acharya, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :14859-14868
[6]   Untangling asthma phenotypes and endotypes [J].
Agache, I. ;
Akdis, C. ;
Jutel, M. ;
Virchow, J. C. .
ALLERGY, 2012, 67 (07) :835-846
[7]   Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes [J].
Baines, Katherine J. ;
Simpson, Jodie L. ;
Wood, Lisa G. ;
Scott, Rodney J. ;
Fibbens, Naomi L. ;
Powell, Heather ;
Cowan, Douglas C. ;
Taylor, D. Robin ;
Cowan, Jan O. ;
Gibson, Peter G. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (04) :997-1007
[8]   Induced Sputum in Asthma: From Bench to Bedside [J].
Bakakos, P. ;
Schleich, F. ;
Alchanatis, M. ;
Louis, R. .
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (10) :1415-1422
[9]   Biomarkers in asthmatic patients: Has their time come to direct treatment? [J].
Berry, Alalia ;
Busse, William W. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (05) :1317-1324
[10]   A sputum gene expression signature predicts oral corticosteroid response in asthma [J].
Berthon, Bronwyn S. ;
Gibson, Peter G. ;
Wood, Lisa G. ;
MacDonald-Wicks, Lesley K. ;
Baines, Katherine J. .
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (06)